Biora Therapeutics, Inc. financial data

Symbol
BIOR on Nasdaq
Industry
Pharmaceutical Preparations
Location
4330 La Jolla Village Drive, Suite 200, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
PROGENITY, INC. (to 4/19/2022), ASCENDANT MDX, INC. (to 6/28/2013)
Latest financial report
10-Q - Q2 2024 - Aug 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 26.8 % -80.4%
Debt-to-equity -126 % +16.7%
Return On Equity 84.5 % +66.3%
Return On Assets -323 % -227%
Operating Margin -508 % -161%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 36.5M shares +163%
Common Stock, Shares, Outstanding 35.9M shares +168%
Entity Public Float 39M USD -66%
Common Stock, Value, Issued 34K USD +209%
Weighted Average Number of Shares Outstanding, Basic 35.7M shares +194%
Weighted Average Number of Shares Outstanding, Diluted 74.2M shares +511%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 12.2M USD -79.9%
Revenue from Contract with Customer, Excluding Assessed Tax 860K USD +778%
Research and Development Expense 31.4M USD +26.7%
Selling and Marketing Expense -1.74M USD -115%
Operating Income (Loss) -68M USD -16.9%
Nonoperating Income (Expense) -55.3M USD -2210%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -86.9M USD
Income Tax Expense (Benefit) -113K USD -1775%
Net Income (Loss) Attributable to Parent -86.6M USD -60.1%
Earnings Per Share, Basic -4.77 USD/shares +11.3%
Earnings Per Share, Diluted -4.99 USD/shares +7.25%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.1M USD -77.5%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Other Assets, Current 406K USD +110%
Assets, Current 9.2M USD -72.8%
Property, Plant and Equipment, Net 1.27M USD -6.14%
Operating Lease, Right-of-Use Asset 1.22M USD -35.5%
Goodwill 6.07M USD 0%
Other Assets, Noncurrent 505K USD -92.2%
Assets 18.3M USD -63.2%
Accounts Payable, Current 7.51M USD +49%
Contract with Customer, Liability, Current 32K USD -23.8%
Liabilities, Current 46M USD +22.1%
Operating Lease, Liability, Noncurrent 402K USD -64.3%
Other Liabilities, Noncurrent 581K USD -86.5%
Liabilities 108M USD -36.9%
Retained Earnings (Accumulated Deficit) -949M USD -10%
Stockholders' Equity Attributable to Parent -89.3M USD +26.1%
Liabilities and Equity 18.3M USD -63.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.5M USD -3.29%
Net Cash Provided by (Used in) Financing Activities 5.1M USD -57.8%
Net Cash Provided by (Used in) Investing Activities 3.01M USD
Common Stock, Shares Authorized 300M shares +82.9%
Common Stock, Shares, Issued 36.7M shares +168%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.39M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.33M USD -79.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 78K USD
Deferred Tax Assets, Valuation Allowance 149M USD +5.31%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0 pure
Deferred Tax Assets, Gross 151M USD +3.58%
Operating Lease, Liability 1.28M USD -33.7%
Depreciation 100K USD -50%
Payments to Acquire Property, Plant, and Equipment 15K USD -6.25%
Lessee, Operating Lease, Liability, to be Paid 1.39M USD
Property, Plant and Equipment, Gross 3.56M USD -5.04%
Operating Lease, Liability, Current 882K USD +8.89%
Lessee, Operating Lease, Liability, to be Paid, Year Two 264K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 590K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 106K USD -55.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 18K USD
Deferred Tax Assets, Operating Loss Carryforwards 140M USD +1.89%
Preferred Stock, Shares Authorized 10M shares 0%
Operating Lease, Payments 300K USD -25%
Operating Leases, Future Minimum Payments, Due in Two Years 590K USD -37.1%
Amortization of Intangible Assets 100K USD -85.7%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 1.02M USD +5.91%
Share-based Payment Arrangement, Expense 15.2M USD +74.5%
Operating Leases, Future Minimum Payments, Due in Three Years 264K USD -47.9%
Operating Leases, Future Minimum Payments Due 1.64M USD -34.5%
Interest Expense 7.9M USD -27.1%